Here are my thoughts on the two statements:
Statement a: “Physicians have the power to influence their patients’ demand for health services and the likelihood of their using this power varies inversely with the level of competition in the medical market.”
I agree with this statement. Physicians are seen as experts in health care, and patients often trust their advice. This means that physicians have a lot of influence over what tests and treatments their patients receive. In a market with low competition, physicians have more power to influence their patients’ demand for health services. This is because they have less fear of losing patients to other providers.
For example, a study published in the journal Health Affairs found that physicians in areas with low competition were more likely to order unnecessary tests and treatments than physicians in areas with high competition. The study also found that the use of unnecessary tests and treatments was associated with higher health care costs.
Statement b: “Widespread use of state-of-the-art screening and other diagnostic tools and techniques would result in a significant reduction in the rate of growth of health care expenditures.”
I disagree with this statement. While widespread use of state-of-the-art screening and diagnostic tools can help to identify and treat diseases early, it is not clear that this would lead to a significant reduction in the rate of growth of health care expenditures.
In fact, some experts believe that widespread use of these tools could actually lead to higher health care costs. This is because they can be expensive to use, and they can lead to unnecessary treatment. For example, a study published in the journal JAMA Internal Medicine found that the use of widespread screening for prostate cancer did not lead to a decrease in the number of deaths from prostate cancer. However, it did lead to an increase in the number of men who were treated for prostate cancer, which resulted in higher health care costs.
The use of state-of-the-art screening and diagnostic tools can be a valuable tool for improving health outcomes. However, it is important to weigh the potential benefits of these tools against the potential costs before making widespread use of them.
Why does it matter?
These two statements matter because they have implications for the way we think about health care and how we allocate resources. If physicians do have the power to influence their patients’ demand for health services, then it is important to consider how this power can be used to improve health outcomes while also controlling costs.
Similarly, if widespread use of state-of-the-art screening and diagnostic tools does not lead to a significant reduction in the rate of growth of health care expenditures, then we need to find other ways to control costs. This could include measures such as increasing competition in the medical market, reducing administrative costs, and changing the way we pay for health care.